Poor
Mostly Not Aligned
Patient Risk:
Low
Summary
The AI response is focused on abuse/misuse/addiction excerpts, which are supported by the provided label text; however, it does not address the user-provided items that are price/generic availability/patent/market factors, which are not supported or verifiable against the provided prescribing information. As a result, overall label alignment is low.
Category Scores
Accurate Statements
Adderall® has a high potential for abuse and misuse that can lead to a substance use disorder, including addiction.
5 WARNINGS (Abuse, Misuse, and Addiction): “Adderall® has a high potential for abuse and misuse... can lead to the development of a substance use disorder, including addiction.”
Adderall® can be diverted for non-medical use into illicit channels or distribution.
5 WARNINGS (Abuse, Misuse, and Addiction): “Adderall® can be diverted for non-medical use into illicit channels or distribution...”
Misuse/abuse can result in overdose and death, with risk increased with higher doses or unapproved methods of administration such as snorting or injection.
5 WARNINGS (Abuse, Misuse, and Addiction): “Misuse and abuse... can result in overdose and death... increased with higher doses or unapproved methods... such as snorting or injection.”
Adderall® contains amphetamine and is a Schedule II controlled substance.
DRUG ABUSE AND DEPENDENCE (Controlled Substance): “Adderall® contains amphetamine, a Schedule II controlled substance.”
Adderall® may produce physical dependence.
DRUG ABUSE AND DEPENDENCE (Dependence): “Adderall® may produce physical dependence…”
Unsupported Statements
A 30-day supply of 10 mg Adderall XR extended-release capsules typically costs around $270.
Not supported in the provided prescribing information excerpts (label provided concerns warnings/contraindications/dosing generalities, not pricing).
The price of Adderall XR can vary based on dosage, quantity purchased, and the pharmacy.
Not supported in the provided prescribing information excerpts.
The price of Adderall XR is influenced by the manufacturer's pricing strategies, complexity of extended-release formulation, and market demand.
Not supported in the provided prescribing information excerpts.
Insurance coverage can lower the out-of-pocket expense for individuals with prescription drug plans via copays.
Not supported in the provided prescribing information excerpts.
Generic versions of Adderall XR are generally available at a lower cost than the brand-name product.
Not supported in the provided prescribing information excerpts.
Generic Adderall XR is available from manufacturers such as Teva Pharmaceuticals.
Not supported in the provided prescribing information excerpts.
Generic drugs commonly cost less after patent protections expire, allowing multiple manufacturers to produce and sell versions of the medication.
Not supported in the provided prescribing information excerpts.
Patent exclusivity for Adderall XR has already expired.
Not supported in the provided prescribing information excerpts.
Patent exclusivity being expired has enabled the introduction of generic alternatives.
Not supported in the provided prescribing information excerpts.
Generic availability of Adderall XR has been attributed to the loss of market exclusivity.
Not supported in the provided prescribing information excerpts.
Patients can compare prices across different pharmacies to reduce the cost of Adderall XR.
Not supported in the provided prescribing information excerpts.
Prescription discount cards or coupons can be used to reduce the cost of Adderall XR.
Not supported in the provided prescribing information excerpts.
Insurance providers may offer preferred generic options or formulary coverage to reduce out-of-pocket cost for Adderall XR.
Not supported in the provided prescribing information excerpts.
Discount services such as GoodRx can offer discounts for people without insurance.
Not supported in the provided prescribing information excerpts.
Adderall XR is available in strengths including 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg extended-release capsules.
Not supported in the provided prescribing information excerpts.
A 30-day supply of 20 mg Adderall XR capsules might cost approximately $340.
Not supported in the provided prescribing information excerpts.
A 30-day supply of 30 mg Adderall XR capsules could be around $380.
Not supported in the provided prescribing information excerpts.
Contradictions
Important Omissions
Evaluation of the user-provided non-label claims (pricing, patent exclusivity, generic manufacturer availability, and Adderall XR formulation/strengths) against the FDA-approved label.
Importance:
High
Word-for-word mapping of a specific user claim (the AI response notes that no specific user claim text was provided to map word-for-word).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only on-label substance-specific claims addressed abuse/misuse/addiction risk and dependence, which are supported by provided label excerpts. However, multiple unsupported claims about pricing/generics/manufacturers could mislead non-clinical decision-making; the label-safety risk is therefore assessed as low, but overall label alignment is poor.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Not Aligned
Primary Issue
The response does not evaluate or substantiate the majority of user-provided claims (pricing, patent/generic availability, manufacturer examples, and strength availability) using the provided FDA label excerpts; only abuse/misuse/addiction and dependence-related label content is addressed.
Suggested Improvement
Restrict claims to what is supported by the provided FDA-approved label sections, or provide the specific label excerpts that support pricing/generic/strength statements; otherwise mark them as unsupported/unknown relative to the provided prescribing information.